| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 11,621,000 | 10,984,000 | 10,867,000 | 12,346,000 | | Cost of Revenue | 1,789,000 | 1,756,000 | 1,408,000 | 1,715,000 | | | Gross Profit | 9,832,000 | 9,228,000 | 9,459,000 | 10,631,000 | | | Operating Expenses | | Research Development | 1,632,000 | 1,695,000 | 1,705,000 | 2,303,000 | | Selling General and Administrative | 3,282,000 | 3,407,000 | 2,819,000 | 3,659,000 | | Non Recurring | 178,000 | 494,000 | 554,000 | 1,407,000 | | Others | 594,000 | 583,000 | 578,000 | 605,000 | | | | Total Operating Expenses | 5,686,000 | 6,179,000 | 5,656,000 | 7,974,000 | | | | Operating Income or Loss | 4,146,000 | 3,049,000 | 3,803,000 | 2,657,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (175,000) |
-
|
-
| (1,516,000) | | Earnings Before Interest And Taxes | 3,971,000 | 3,049,000 | 3,803,000 | 1,141,000 | | Interest Expense |
-
|
-
|
-
| 516,000 | | Income Before Tax | 3,971,000 | 3,049,000 | 3,803,000 | 625,000 | | Income Tax Expense | 1,092,000 | 786,000 | 1,074,000 | 394,000 | | Minority Interest | (3,000) | (6,000) |
-
| (5,000) | | | | Net Income From Continuing Ops | 2,885,000 | 2,257,000 | 2,729,000 | 226,000 | | | Non-recurring Events | | Discontinued Operations | 2,000 | 3,000 | 1,000 | 40,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,878,000 | 2,260,000 | 2,730,000 | 266,000 | | Preferred Stock And Other Adjustments |
-
| 1,000 | (1,000) |
-
| | | Net Income Applicable To Common Shares | $2,878,000 | $2,261,000 | $2,729,000 | $266,000 |
|
0.63% Nasdaq 
0.03%
Income Statement
